GNRH1 and polycystic ovary syndrome: Previous studies (5, 6) have shown that the gonadotrophin-releasing hormone (GnRH) antagonist protocol is beneficial to patients with PCOS due to its lower risk of OHSS and is recommended for this population according to the ESHRE guideline (7).